What is Ernexa Therapeutics Inc. Common Stock's Market Cap?

Ernexa Therapeutics Inc. Common Stock's Market Cap is $6.6M, based on as-reported figures from SEC (XBRL) filings.

What is Ernexa Therapeutics Inc. Common Stock's Revenue (TTM)?

Ernexa Therapeutics Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Ernexa Therapeutics Inc. Common Stock's Net Income (TTM)?

Ernexa Therapeutics Inc. Common Stock's Net Income (TTM) is -$12.3M, based on as-reported figures from SEC (XBRL) filings.

What is Ernexa Therapeutics Inc. Common Stock's EBITDA?

Ernexa Therapeutics Inc. Common Stock's EBITDA is -$13.7M, based on as-reported figures from SEC (XBRL) filings.

What is Ernexa Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

Ernexa Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -7.52, based on as-reported figures from SEC (XBRL) filings.

Ernexa Therapeutics Inc. Common Stock (ERNA) Financial Statements

Ernexa Therapeutics Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S74KP5

XNAS · usd

4.02▼ 0.17 (-4.06%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close4.19

Day's Range3.97 – 4.23

52-Week Range0.13 – 15.88

Volume14.9K

Avg Volume36.5K

Share Statistics

Shares Outstanding

Employees5

ExchangeXNAS

Listed2021-03-26

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Ernexa Therapeutics Inc. Common Stock (ERNA)

What is Ernexa Therapeutics Inc. Common Stock's Market Cap?: Ernexa Therapeutics Inc. Common Stock's Market Cap is $6.6M, based on as-reported figures from SEC (XBRL) filings.
What is Ernexa Therapeutics Inc. Common Stock's Revenue (TTM)?: Ernexa Therapeutics Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Ernexa Therapeutics Inc. Common Stock's Net Income (TTM)?: Ernexa Therapeutics Inc. Common Stock's Net Income (TTM) is -$12.3M, based on as-reported figures from SEC (XBRL) filings.
What is Ernexa Therapeutics Inc. Common Stock's EBITDA?: Ernexa Therapeutics Inc. Common Stock's EBITDA is -$13.7M, based on as-reported figures from SEC (XBRL) filings.
What is Ernexa Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: Ernexa Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -7.52, based on as-reported figures from SEC (XBRL) filings.